Biotech Values

[dia76ca]

There are going to be a number of of opportunities for updates on PPHM's progress on the second line NSCLC phase II study. Here are some of them.

Aug, 15: Wedbush Life Sciences Conference
Sep, 5: Stifel Nicolaus Healthcare Conference 2012
Sep, 7: 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology
Sep, 21: Credit Suisse 3rd Annual Small & Mid Cap Conference

I look forward to more data being released as it becomes available. The Chicago Thoracic Oncology Conference should be of particular interest. The two Bavi plus Doce arms MOS is what I most look forward to. It may not even be reached by these dates but that alone is noteworthy.

I expect Dr. Thorpe to be making many presentations in the near future and amending both his slides and presentations as more is learned about targeting PS and PE.